Search research articles
Contact Us
Filters
Showing results (71-80 of 136) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2022
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)
Philip C Mack, Jieling Miao, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 6, 2013
Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536
Edward S Kim, James Moon, Roy S Herbst, et al.
Circulation. Cardiovascular Imaging
|
July 11, 2023
Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
Adam Ioannou, Aldostefano Porcari, Rishi K Patel, et al.
JACC. Cardiovascular Imaging
|
February 18, 2019
Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology
Tushar Kotecha, Ana Martinez-Naharro, Michele Boldrini, et al.
Clinical Lung Cancer
|
August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials
Howard L West, James Moon, Antoinette J Wozniak, et al.
Trials
|
June 2, 2019
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice
Ravi Vijapurapu, Rebecca Kozor, Derralynn A Hughes, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
March 6, 2014
Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification
Ntobeko A B Ntusi, Stefan K Piechnik, Jane M Francis, et al.
American Journal of Clinical Oncology
|
December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)
Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.
JACC. Cardiovascular Imaging
|
November 1, 2020
Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression
Marianna Fontana, Ana Martinez-Naharro, Liza Chacko, et al.
Cancer
|
September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma
Christopher D Lao, James Moon, Vincent T Ma, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 136) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2022
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)
Philip C Mack, Jieling Miao, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 6, 2013
Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536
Edward S Kim, James Moon, Roy S Herbst, et al.
Circulation. Cardiovascular Imaging
|
July 11, 2023
Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
Adam Ioannou, Aldostefano Porcari, Rishi K Patel, et al.
JACC. Cardiovascular Imaging
|
February 18, 2019
Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology
Tushar Kotecha, Ana Martinez-Naharro, Michele Boldrini, et al.
Clinical Lung Cancer
|
August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials
Howard L West, James Moon, Antoinette J Wozniak, et al.
Trials
|
June 2, 2019
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice
Ravi Vijapurapu, Rebecca Kozor, Derralynn A Hughes, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
March 6, 2014
Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification
Ntobeko A B Ntusi, Stefan K Piechnik, Jane M Francis, et al.
American Journal of Clinical Oncology
|
December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)
Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.
JACC. Cardiovascular Imaging
|
November 1, 2020
Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression
Marianna Fontana, Ana Martinez-Naharro, Liza Chacko, et al.
Cancer
|
September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma
Christopher D Lao, James Moon, Vincent T Ma, et al.
Page
of 14